{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:14:37Z","timestamp":1768709677967,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recent developments related to a safe and effective nonabsorbable antibiotic, rifaximin, and identification of postinfectious irritable bowel syndrome as a frequent sequela call for a need to reconsider the value of primary prevention of traveler\u2019s diarrhea (TD) with antibiotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Randomized, placebo-controlled, double-blind studies evaluating the effectiveness and safety of rifaximin or a fluoroquinolone chemoprophylaxis against TD were pooled using a random effects model and assessed for heterogeneity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The nine studies (four rifaximin and five fluoroquinolone) included resulted in pooled relative risk estimates of 0.33 (95% CI = 0.24\u20130.45, <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup> = 3.1%) and 0.12 (95% CI = 0.07\u20130.20, <jats:italic>I<\/jats:italic>\n              <jats:sup>2<\/jats:sup> =0.0%), respectively. Similar rates of treatment emergent adverse events were found between antibiotic and placebo groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This meta-analysis supports the effectiveness of antibiotics in preventing TD. However, further studies that include prevention of secondary chronic health outcomes among travelers to different geographic regions, and a formal risk-benefit analysis for antibiotic chemoprophylaxis, are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2046-4053-1-39","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T14:14:08Z","timestamp":1346163248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Effectiveness of rifaximin and fluoroquinolones in preventing travelers\u2019 diarrhea (TD): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"1","author":[{"given":"Sanjin","family":"Alajbegovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah E","family":"Atherly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","volume":"80","author":"N Shah","year":"2009","unstructured":"Shah N, DuPont HL, Ramsey DJ: Global etiology of travelers\u2019 diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009, 80: 609-614.","journal-title":"Am J Trop Med Hyg"},{"key":"30_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1708-8305.2007.00159.x","volume":"14","author":"MS Riddle","year":"2007","unstructured":"Riddle MS, Halvorson HA, Shiau D, Althoff J, Monteville MR, Shaheen H, Horvath EP, Armstrong AW: Acute gastrointestinal infection, respiratory illness, and noncombat injury among US military personnel during Operation Bright Star 2005, in Northern Egypt. J Travel Med. 2007, 14: 392-401. 10.1111\/j.1708-8305.2007.00159.x.","journal-title":"J Travel Med"},{"issue":"Suppl 8","key":"30_CR3","doi-asserted-by":"publisher","first-page":"S531","DOI":"10.1086\/432947","volume":"41","author":"DR Shlim","year":"2005","unstructured":"Shlim DR: Looking for evidence that personal hygiene precautions prevent traveler\u2019s diarrhea. Clin Infect Dis. 2005, 41 (Suppl 8): S531-S535.","journal-title":"Clin Infect Dis"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-12-43","volume":"12","author":"AE Heywood","year":"2012","unstructured":"Heywood AE, Zhang M, MacIntyre CR, Seale H: Travel risk behaviours and uptake of pre-travel health preventions by university students in Australia. BMC Infect Dis. 2012, 12: 43-10.1186\/1471-2334-12-43.","journal-title":"BMC Infect Dis"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1708-8305.2010.00458.x","volume":"17","author":"EA Yanni","year":"2010","unstructured":"Yanni EA, Marano N, Han P, Edelson PJ, Blumensaadt S, Becker M, Dwyer S, Crocker K, Daley T, Davis X, Gallagher N, Balaban V, McCarron M, Mounts A, Lipman H, Brown C, Kozarsky P: Knowledge, attitudes, and practices of US travelers to Asia regarding seasonal influenza and H5N1 avian influenza prevention measures. J Travel Med. 2010, 17: 374-381. 10.1111\/j.1708-8305.2010.00458.x.","journal-title":"J Travel Med"},{"key":"30_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1708-8305.2010.00405.x","volume":"17","author":"K Namikawa","year":"2010","unstructured":"Namikawa K, Iida T, Ouchi K, Kimura M: Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake. J Travel Med. 2010, 17: 171-175. 10.1111\/j.1708-8305.2010.00405.x.","journal-title":"J Travel Med"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1708-8305.2009.00322.x","volume":"16","author":"LB Hartjes","year":"2009","unstructured":"Hartjes LB, Baumann LC, Henriques JB: Travel health risk perceptions and prevention behaviors of US study abroad students. J Travel Med. 2009, 16: 338-343. 10.1111\/j.1708-8305.2009.00322.x.","journal-title":"J Travel Med"},{"key":"30_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2310\/7060.2005.00006","volume":"12","author":"R Steffen","year":"2005","unstructured":"Steffen R, Connor BA: Vaccines in travel health: from risk assessment to priorities. J Travel Med. 2005, 12: 26-35.","journal-title":"J Travel Med"},{"key":"30_CR9","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1001\/jama.1985.03350420112029","volume":"253","author":"Office of Medical Applications of Research, National Institutes of Health; NIH Consensus Development Conference","year":"1985","unstructured":"Office of Medical Applications of Research, National Institutes of Health; NIH Consensus Development Conference: Travelers\u2019 diarrhea. JAMA. 1985, 253: 2700-2704.","journal-title":"JAMA"},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/archinte.1988.00380110071015","volume":"148","author":"RR Reves","year":"1988","unstructured":"Reves RR, Johnson PC, Ericsson CD, DuPont HL: A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers\u2019 diarrhea. Arch Intern Med. 1988, 148: 2421-2427. 10.1001\/archinte.1988.00380110071015.","journal-title":"Arch Intern Med"},{"key":"30_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2165\/00019053-199609050-00002","volume":"9","author":"MA Thomson","year":"1996","unstructured":"Thomson MA, Booth IW: Treatment of traveller\u2019s diarrhoea: economic aspects. Pharmacoeconomics. 1996, 9: 382-391. 10.2165\/00019053-199609050-00002.","journal-title":"Pharmacoeconomics"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.gtc.2006.03.008","volume":"35","author":"HL DuPont","year":"2006","unstructured":"DuPont HL: New insights and directions in travelers\u2019 diarrhea. Gastroenterol Clin North Am. 2006, 35: 337-353. 10.1016\/j.gtc.2006.03.008. viii\u2013ix","journal-title":"Gastroenterol Clin North Am"},{"key":"30_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/0003-4819-142-10-200505170-00012","volume":"142","author":"SL Gorbach","year":"2005","unstructured":"Gorbach SL: How to hit the runs for fifty million travelers at risk. Ann Intern Med. 2005, 142: 861-862.","journal-title":"Ann Intern Med"},{"key":"30_CR14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1086\/508782","volume":"43","author":"DR Hill","year":"2006","unstructured":"Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, DuPont HL, Bia FJ, Fischer PR, Ryan ET, Infectious Diseases Society of America: The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006, 43: 1499-1539. 10.1086\/508782.","journal-title":"Clin Infect Dis"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1572-0241.2006.00654.x","volume":"101","author":"HA Halvorson","year":"2006","unstructured":"Halvorson HA, Schlett CD, Riddle MS: Postinfectious irritable bowel syndrome: a meta-analysis. Am J Gastroenterol. 2006, 101: 1894-1899. 10.1111\/j.1572-0241.2006.00654.x.","journal-title":"Am J Gastroenterol"},{"key":"30_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2036.2007.03399.x","volume":"26","author":"M Thabane","year":"2007","unstructured":"Thabane M, Kottachchi DT, Marshall JK: Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007, 26: 535-544. 10.1111\/j.1365-2036.2007.03399.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"30_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","volume":"26","author":"HL Koo","year":"2009","unstructured":"Koo HL, DuPont HL: Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2009, 26: 17-25.","journal-title":"Curr Opin Gastroenterol"},{"key":"30_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/14787210.4.3.417","volume":"4","author":"HL Koo","year":"2006","unstructured":"Koo HL, DuPont HL: Current and future developments in travelers\u2019 diarrhea therapy. Expert Rev Anti Infect Ther. 2006, 4: 417-427. 10.1586\/14787210.4.3.417.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"30_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0924-8579(02)00282-0","volume":"21","author":"CD Ericsson","year":"2003","unstructured":"Ericsson CD: Travellers\u2019 diarrhoea. Int J Antimicrob Agents. 2003, 21: 116-124. 10.1016\/S0924-8579(02)00282-0.","journal-title":"Int J Antimicrob Agents"},{"key":"30_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2036.2008.03647.x","volume":"27","author":"HL DuPont","year":"2008","unstructured":"DuPont HL: Systematic review: prevention of travellers\u2019 diarrhoea. Aliment Pharmacol Ther. 2008, 27: 741-751. 10.1111\/j.1365-2036.2008.03647.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/00003495-200666030-00003","volume":"66","author":"HL DuPont","year":"2006","unstructured":"DuPont HL: Travellers\u2019 diarrhoea: contemporary approaches to therapy and prevention. Drugs. 2006, 66: 303-314. 10.2165\/00003495-200666030-00003.","journal-title":"Drugs"},{"key":"30_CR22","first-page":"2","volume":"18","author":"AS Chapman","year":"2011","unstructured":"Chapman AS, Witkop CT, Escobar JD, Schlorman CA, DeMarcus LS, Marmer LM, Crum ME: Norovirus outbreak associated with person-to-person transmission, U.S. Air Force Academy, July 2011. MSMR. 2011, 18: 2-5.","journal-title":"MSMR"},{"key":"30_CR23","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA: A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006, 25: 3443-3457. 10.1002\/sim.2380.","journal-title":"Stat Med"},{"key":"30_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1128\/AAC.30.5.671","volume":"30","author":"PC Johnson","year":"1986","unstructured":"Johnson PC, Ericsson CD, Morgan DR, Dupont HL, Cabada FJ: Lack of emergence of resistant fecal flora during successful prophylaxis of traveler\u2019s diarrhea with norfloxacin. Antimicrob Agents Chemother. 1986, 30: 671-674. 10.1128\/AAC.30.5.671.","journal-title":"Antimicrob Agents Chemother"},{"key":"30_CR25","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1093\/cid\/cir916","volume":"54","author":"D Cohen","year":"2012","unstructured":"Cohen D, Shoham O, Orr N, Muhsen K: An inverse and independent association between Helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases. Clin Infect Dis. 2012, 54: e35-e42. 10.1093\/cid\/cir916.","journal-title":"Clin Infect Dis"},{"key":"30_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","volume":"142","author":"HL DuPont","year":"2005","unstructured":"DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F: A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers\u2019 diarrhea. Ann Intern Med. 2005, 142: 805-812.","journal-title":"Ann Intern Med"},{"key":"30_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1708-8305.2011.00549.x","volume":"18","author":"J Flores","year":"2011","unstructured":"Flores J, DuPont HL, Jiang ZD, Okhuysen PC, Melendez-Romero JH, Gonzalez-Estrada A, Carrillo I, Paredes M: A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers\u2019 diarrhea in Mexico during the dry season. J Travel Med. 2011, 18: 333-336. 10.1111\/j.1708-8305.2011.00549.x.","journal-title":"J Travel Med"},{"key":"30_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1708-8305.2009.00385.x","volume":"17","author":"F Martinez-Sandoval","year":"2010","unstructured":"Martinez-Sandoval F, Ericsson CD, Jiang ZD, Okhuysen PC, Romero JH, Hernandez N, Forbes WP, Shaw A, Bortey E, DuPont HL: Prevention of travelers\u2019 diarrhea with rifaximin in US travelers to Mexico. J Travel Med. 2010, 17: 111-117. 10.1111\/j.1708-8305.2009.00385.x.","journal-title":"J Travel Med"},{"key":"30_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0163-4453(94)92393-0","volume":"28","author":"H Parry","year":"1994","unstructured":"Parry H, Howard AJ, Galpin OP, Hassan SP: The prophylaxis of travellers\u2019 diarrhoea: a double blind placebo controlled trial of ciprofloxacin during a Himalayan expedition. J Infect. 1994, 28: 337-338. 10.1016\/S0163-4453(94)92393-0.","journal-title":"J Infect"},{"key":"30_CR30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/BF01963753","volume":"8","author":"CM Rademaker","year":"1989","unstructured":"Rademaker CM, Hoepelman IM, Wolfhagen MJ, Beumer H, Rozenberg-Arska M, Verhoef J: Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers\u2019 diarrhea. Eur J Clin Microbiol Infect Dis. 1989, 8: 690-694. 10.1007\/BF01963753.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"30_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/jac\/20.4.563","volume":"20","author":"J Wistr\u00f6m","year":"1987","unstructured":"Wistr\u00f6m J, Norrby SR, Burman LG, Lundholm R, Jellheden B, Englund G: Norfloxacin versus placebo for prophylaxis against travellers\u2019 diarrhoea. J Antimicrob Chemother. 1987, 20: 563-574. 10.1093\/jac\/20.4.563.","journal-title":"J Antimicrob Chemother"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1086\/503039","volume":"42","author":"DN Taylor","year":"2006","unstructured":"Taylor DN, McKenzie R, Durbin A, Carpenter C, Atzinger CB, Haake R, Bourgeois AL: Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis. 2006, 42: 1283-1288. 10.1086\/503039.","journal-title":"Clin Infect Dis"},{"key":"30_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1708-8305.1994.tb00580.x","volume":"1","author":"JE Heck","year":"1994","unstructured":"Heck JE, Staneck JL, Cohen MB, Weckbach LS, Giannella RA, Hawkins J, Tosiello R: Prevention of travelers\u2019 diarrhea: ciprofloxacin versus trimethoprim\/sulfamethoxazole in adult volunteers working in Latin America and the Caribbean. J Travel Med. 1994, 1: 136-142. 10.1111\/j.1708-8305.1994.tb00580.x.","journal-title":"J Travel Med"},{"key":"30_CR34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4269\/ajtmh.1990.42.160","volume":"42","author":"DA Scott","year":"1990","unstructured":"Scott DA, Haberberger RL, Thornton SA, Hyams KC: Norfloxacin for the prophylaxis of travelers\u2019 diarrhea in U.S. military personnel. Am J Trop Med Hyg. 1990, 42: 160-164.","journal-title":"Am J Trop Med Hyg"},{"key":"30_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1708-8305.2006.00009.x","volume":"13","author":"JA Yates","year":"2006","unstructured":"Yates JA, Stetz LC: Reiter\u2019s syndrome (reactive arthritis) and travelers\u2019 diarrhea. J Travel Med. 2006, 13: 54-56. 10.1111\/j.1708-8305.2006.00009.x.","journal-title":"J Travel Med"},{"key":"30_CR36","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1469-0691.2004.00983.x","volume":"10","author":"JP Butzler","year":"2004","unstructured":"Butzler JP: Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004, 10: 868-876. 10.1111\/j.1469-0691.2004.00983.x.","journal-title":"Clin Microbiol Infect"},{"key":"30_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10620-007-9853-x","volume":"53","author":"AK Tuteja","year":"2008","unstructured":"Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Hale DC: Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci. 2008, 53: 271-276. 10.1007\/s10620-007-9853-x.","journal-title":"Dig Dis Sci"},{"key":"30_CR38","first-page":"1970","volume":"98","author":"SD Parry","year":"2003","unstructured":"Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR: Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case\u2013control study: Frequency of FGID After Gastroenteritis. Am J Gastroenterol. 2003, 98: 1970-1975.","journal-title":"Am J Gastroenterol"},{"key":"30_CR39","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1007\/s10620-011-1762-3","volume":"56","author":"CK Porter","year":"2011","unstructured":"Porter CK, Gloor K, Cash BD, Riddle MS: Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment. Dig Dis Sci. 2011, 56: 3262-3269. 10.1007\/s10620-011-1762-3.","journal-title":"Dig Dis Sci"},{"key":"30_CR40","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1007\/s10620-011-1766-z","volume":"56","author":"KH Trivedi","year":"2011","unstructured":"Trivedi KH, Schlett CD, Tribble DR, Monteville MR, Sanders JW, Riddle MS: The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East. Dig Dis Sci. 2011, 56: 3602-3609. 10.1007\/s10620-011-1766-z.","journal-title":"Dig Dis Sci"},{"key":"30_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1708-8305.2011.00529.x","volume":"18","author":"R Pitzurra","year":"2011","unstructured":"Pitzurra R, Fried M, Rogler G, Rammert C, Tschopp A, Hatz C, Steffen R, Mutsch M: Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. J Travel Med. 2011, 18: 250-256. 10.1111\/j.1708-8305.2011.00529.x.","journal-title":"J Travel Med"},{"key":"30_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1572-0241.2003.07297.x","volume":"98","author":"A Ilnyckyj","year":"2003","unstructured":"Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR: Post-traveler\u2019s diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol. 2003, 98: 596-599. 10.1111\/j.1572-0241.2003.07297.x.","journal-title":"Am J Gastroenterol"},{"key":"30_CR43","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/j.1572-0241.2004.30435.x","volume":"99","author":"PC Okhuysen","year":"2004","unstructured":"Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL: Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004, 99: 1774-1778. 10.1111\/j.1572-0241.2004.30435.x.","journal-title":"Am J Gastroenterol"},{"key":"30_CR44","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1086\/507540","volume":"43","author":"E Stermer","year":"2006","unstructured":"Stermer E, Lubezky A, Potasman I, Paster E, Lavy A: Is traveler\u2019s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis. 2006, 43: 898-901. 10.1086\/507540.","journal-title":"Clin Infect Dis"},{"key":"30_CR45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/gut.51.3.410","volume":"51","author":"KR Neal","year":"2002","unstructured":"Neal KR, Barker L, Spiller RC: Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002, 51: 410-413. 10.1136\/gut.51.3.410.","journal-title":"Gut"},{"key":"30_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cgh.2007.01.007","volume":"5","author":"H T\u00f6rnblom","year":"2007","unstructured":"T\u00f6rnblom H, Holmvall P, Svenungsson B, Lindberg G: Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol. 2007, 5: 461-464. 10.1016\/j.cgh.2007.01.007.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"30_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1708-8305.2008.00270.x","volume":"16","author":"J Lundkvist","year":"2009","unstructured":"Lundkvist J, Steffen R, J\u00f6nsson B: Cost-benefit of WC\/rBS oral cholera vaccine for vaccination against ETEC-caused travelers\u2019 diarrhea. J Travel Med. 2009, 16: 28-34. 10.1111\/j.1708-8305.2008.00270.x.","journal-title":"J Travel Med"},{"key":"30_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00019053-200624010-00002","volume":"24","author":"S Maxion-Bergemann","year":"2006","unstructured":"Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R: Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics. 2006, 24: 21-37. 10.2165\/00019053-200624010-00002.","journal-title":"Pharmacoeconomics"},{"key":"30_CR49","first-page":"209","volume":"68","author":"HO Lobel","year":"1990","unstructured":"Lobel HO, Phillips-Howard PA, Brandling-Bennett AD, Steffen R, Campbell CC, Huong AY, Were JB, Moser R: Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ. 1990, 68: 209-215.","journal-title":"Bull World Health Organ"},{"key":"30_CR50","first-page":"313","volume":"68","author":"R Steffen","year":"1990","unstructured":"Steffen R, Heusser R, M\u00e4chler R, Bruppacher R, Naef U, Chen D, Hofmann AM, Somaini B: Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Organ. 1990, 68: 313-322.","journal-title":"Bull World Health Organ"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-1-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:45:51Z","timestamp":1630525551000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-1-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-1-39","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"31 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}